New research results now published from Lund University's MASAI trial are even better than the initial findings from last ...

NEW YORK - IO Biotech (IOBT), a clinical-stage biopharmaceutical company valued at $58.63 million, has published results from a preclinical study on its second cancer vaccine candidate, IO112, which ...

Guo has not only been about software and assay development but also about identifying new drugs and new indications for existing drugs for the treatment of lung cancer and breast cancer. Through the ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

The global incidence of cancer reached 20 million in 2022 and is projected to rise to 33·1 million by 2050.1 Amid the growing ...

On World Cancer Day, we look at advances in cancer research, prevention and treatment that bring new hope and are extending ...